ClinicalTrials.gg
CompletedNCT05234515BUGS-IN-IFUpdated Apr 18, 2023

Bacteriology of sUrGical Site INfection Following Surgery for Intestinal Failure

An observational study in Surgical Wound Infection, Surgical Site Infection and Bacteria Infection Mechanism, sponsored by London North West Healthcare NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-18.

Sponsored by London North West Healthcare NHS Trust · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
21
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 21 studies in Surgical Wound Infection with a site in United Kingdom — 2 open to participants now, 2 under way, 1 of them phase 3. Surgical Wound Infection · United Kingdom.

Started
2022
with 1 other
Observational
8 of 21
none open now
Registered
18th of 21
by date
Lead sponsor
1 of 21
London North West Healthcare NHS Trust

Among the 21 studies in Surgical Wound Infection with a site in United Kingdom, this one is one of 2 that started in 2022, is one of 8 observational ones, and was the 18th registered.

Surgical Wound Infection

746 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.

Browse Surgical Wound Infection studies →

Open to participants now

2 of the 21 studies in Surgical Wound Infection with a site in United Kingdom are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 84 Surgical Wound Infection studies recruiting now, 60 (71%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Surgical Wound Infection with a site in United Kingdom, or all of them as a file.
02

Study summary

This is a prospective observational study of patients undergoing planned surgery for intestinal failure. The aims of the study are:

  • To prospectively characterise preoperative bacterial populations amongst patients undergoing surgery for intestinal failure
  • To examine the relationship between preoperative bacteriology and surgical site infection (SSI) in this patient group
  • To investigate the effect of surgery and surgical site infection on generic and wound specific quality of life measures
03

Conditions studied

  • Surgical Wound Infection
  • Surgical Site Infection
  • Bacteria Infection Mechanism
  • Intestinal Disease
  • Intestinal Fistula
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients will be recruited from the intestinal failure unit at St Mark's hospital, London North West University Healthcare NHS Trust.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged >18 year
  • Diagnosis of intestinal failure or enterocutaneous fistula
  • Undergoing elective surgery within St Mark's hospital IF unit

Exclusion criteria

Exclusion Criteria:

  • Unable or unwilling to provide
  • Pregnant
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
21 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Patients with intestinal failure or an enterocutaneous fistula undergoing elective surgery.

    Adult patients with a diagnosis of intestinal failure (IF) or an enterocutaneous fistula (ECF) undergoing planned surgery in our unit.

    Diagnostic Test: Microbiology swab · Other: Questionnaire

Interventions

  • Diagnostic testMicrobiology swab

    Patients will have swabs taken from the nose, mouth, umbilical skin, groin skin, fistula(e), stoma(s) and vascular access device prior to surgery. Patients will be followed for 90 days postoperatively for surgical site infection (SSI) as defined by the centre for disease control (CDC) criteria 2021. Patients who develop an SSI will have both preoperative and postoperative samples sent for genome sequencing.

  • OtherQuestionnaire

    Patients will complete baseline preoperative questionnaires which will be repeated at 30 days and 90 days. These will evaluate generic and wound specific quality of life as well as decision conflict/decision regret.

06

What researchers measure

Primary outcomes

  1. Clinical Surgical Site Infection (SSI)

    Classified as either superficial, deep or organ space as defined by the centre for disease control (CDC) classification 2021

    Time frame: 0-90 days

  2. Microbiological

    Preoperative colonisation species, Organisms cultured from SSI, Correlation to preoperative samples

    Time frame: 0-90 days

  3. Change in Generic Quality of Life Score

    Generic health scores quantified by the validated EuroQoL 5 dimension, 5 level questionnaire (EQ5D-5L) at baseline, 30 and 90 days. (Minimum score 5, Maximum score 25)

    Time frame: Baseline - 90 days

  4. Change in Wound Specific Quality of Life Score

    Quantified by the Wound-QoL questionnaire, a validated 17 item scale at baseline, 30 and 90 days (Minimum score 0, Maximum score 68)

    Time frame: Baseline - 90 days

  5. Decision conflict

    Preoperative decision conflict scores quantified by decision conflict scale (DCS), a validated 16 point scale (Minimum score 0, Maximum score 64)

    Time frame: Day 0

  6. Change in Decision Regret

    Postoperative decision regret scores quantified by the decision regret scale (DRS) a validated 5 item questionnaire, at 30 and 90 days. (Minimum score 5, Maximum score 25)

    Time frame: 30 and 90 days

Secondary outcomes

  1. Length of stay

    Duration of index hospital admission, measured in days

    Time frame: from day of surgery (day 0)

  2. Complications

    Classified using the Clavien-Dindo classification(I-V)

    Time frame: 90 days

  3. Abdominal wound healing

    Classified as either 'completely healed' OR 'incompletely healed'

    Time frame: 90 days

07

Study locations

1 site
  • St Marks Hospital
    Harrow, London HA1 3UJ, United Kingdom
08

References and documents

Individual participant data

Plan to share: No — No IPD will be shared. Summary findings will be disseminated to other health care workers and patient groups at conference where the work will be presented. The data will be submitted to a peer-reviewed medical journal for publication. Internal reports will update on the progress of the work. The data will be under the ownership of London north west university healthcares trust (LNWUHT). The PhD student involved, and their team will have rights to publish the data. Patient participants will be notified of publications and asked if they would like to receive copies following the study period.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2022 to primary completion in Oct 2022, 9 months.

Of 65 non-industry observational studies under Surgical Wound Infection, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 53. This study's 9 months is below that.

Counting every sponsor, half of 68 studies reached it within 21 months; a quarter within 9 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2021
First posted
Feb 10, 2022
StartActual
Jan 14, 2022
Primary completionActual
Oct 30, 2022
CompletionActual
Feb 20, 2023
Last update
Apr 18, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05234515
Lead sponsor
London North West Healthcare NHS Trust
Responsible party
Sponsor
First posted
Feb 10, 2022
Start date
Jan 14, 2022
Primary completion
Oct 30, 2022
Completion
Feb 20, 2023
Last update
Apr 18, 2023

Study contacts

Carolynne F Vaizey
principal investigator · St Marks Hospital & Academic Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion